| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |